glp-1 drugs and cancer Receptor Agonists: Benefits Risks in Colorectal Glucagon-like peptide 1 receptor agonists
Description
doi: 10.1152/ajpendo.00330.2023 [DOI] [PMC free article] [PubMed] [Google Scholar] 170
Over time, this can lead to a variety of health problems, including weight gain, high blood pressure, and an increased risk of type 2 diabetes
doi: 10.1007/s00125-005-0128-9 49 NishiHHigashiharaTInagiR
By type of molecule the market is segmented into biologics and small molecules, by active compound used market is categorized into dulaglutide, liraglutide, orforglipron, retatrutide, semaglutide, survodutide, tirzepatide and other active compounds
